Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 960 of 1,261
  1. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  2. US 7968298

    Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  3. US 7968726

    Methods of preparing imidazole-based bicyclic compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  4. US 7968714

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  5. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  6. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  7. US 7968664

    Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  8. US 7968559

    Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  9. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  10. US 7968615

    Polymerizable monomer, polymerizable composition and dental material

    Kuraray Medical Inc. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  11. EP 2336066

    Spule mit darauf aufgewickelter beschichteter Folienbahn

    ACINO AG [DE] · Granted Jun 22, 2011 · Expires Jun 17, 2031

    granted
  12. US 7964186

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  13. US 7964615

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

    Almirall, S.A. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  14. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  15. US 7964576

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  16. US 7964561

    Protein formulations for use at elevated temperatures

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  17. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  18. US 7964217

    Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

    Nektar Therapeutics · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  19. US 7964187

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  20. US 7964702

    Phalloidin derivatives and methods for their synthesis

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  21. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  22. US 7964712

    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  23. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  24. US 7964573

    Regulating expression of transient receptor potential channel genes

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.